uterine myoma. Disorder of uterus NOS
Conditions
Interventions
Intervention 1: Intervention group: Fifty women who will Receive one pack of Misoprostol (400µg) before surgery. Intervention 2: control group are 50 women who will receive one pack of Placebo before
Treatment - Drugs
Intervention group: Fifty women who will Receive one pack of Misoprostol (400µg) before surgery.
control group are 50 women who will receive one pack of Placebo before surgery.
Sponsors
Vice chancellor for research, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who choose to be treated by TAH with BSO or without BSO; Their last delivery was 24 months ago or before. Exclusion criteria: History of pelvic surgery; Severe heart or lung disease; Hematologic Disorders; Glaucoma; Asthma; liver disease; Endometriosis; Adnexal masses; history of myomectomy; Those who have taken GnRH agonist before surgery; allergy to misoprostol, Diastolic pressure above 100.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of Hemoglobin. Timepoint: 24 hours after interventional. Method of measurement: complete blood count. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding during surgery. Timepoint: during surgery. Method of measurement: The amount of blood inside the suction device , The gravity of bloody sponges. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr. Salme Dadgar
Mashhad University of Medical Sciences
Outcome results
None listed